222 related articles for article (PubMed ID: 29562465)
21. Recombinant human thrombopoietin improved platelet engraftment after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.
Gu J; Liu J; Li X; Zou W; Huang B; Chen M; Li J
Cancer Med; 2021 Nov; 10(21):7641-7649. PubMed ID: 34569193
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of efficacy of immunosuppressive therapy plus recombinant human thrombopoietin for children with severe aplastic anemia].
Zhou K; Liu CX; Li Y; Li JP; Fan HH; Zhang L; Jing LP; Peng GX; Ye L; Li Y; Song L; Zhao X; Yang WR; Wu ZJ; Chen F; Zhang FK
Zhonghua Er Ke Za Zhi; 2017 Jul; 55(7):523-528. PubMed ID: 28728262
[No Abstract] [Full Text] [Related]
23. High- vs regular-dose recombinant human thrombopoietin plus cyclosporine A in patients with newly diagnosed non-severe aplastic anemia: a retrospective cohort study.
Yang Y; Hu Q; Yang C; Chen M; Han B
Hematology; 2024 Dec; 29(1):2298523. PubMed ID: 38156735
[TBL] [Abstract][Full Text] [Related]
24. Eltrombopag can promote platelet implantation after allogeneic hematopoietic stem cell transplantation as safely and similarly to thrombopoietin.
Li Y; Kong F; Bai G; Jiang Y; Zhang W; Sun X; Sui X; Li Y; Ding M; Yuan D; Wang X; Fang X
Front Immunol; 2024; 15():1340908. PubMed ID: 38650933
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy and safety of rhTPO in the treatment of pediatric primary immune thrombocytopenia].
Huang Y; Liu X; Xue F; Chen Y; Liu W; Fu R; Zhang L; Yang R
Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):511-4. PubMed ID: 26134019
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness analysis of rhTPO and rhIL-11 in the treatment of chemotherapy-induced thrombocytopenia in hematological tumors based on real-world data.
Zhang JJ; Zhao R; Xia F; Li Y; Wang RW; Guan X; Zhu JG; Ma AX
Ann Palliat Med; 2022 Aug; 11(8):2709-2719. PubMed ID: 36064361
[TBL] [Abstract][Full Text] [Related]
27. [Effect of Recombinant Human Thrombopoietin (rhTPO) on Hematopoietic Reconstitution in Allogeneic Hematopoietic Stem Cell Transplantation Model].
Qiu J; Han LY; Xing HY; Gao KL; Bian TR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):241-246. PubMed ID: 36765506
[TBL] [Abstract][Full Text] [Related]
28. Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study.
Wolff SN; Herzig R; Lynch J; Ericson SG; Greer JP; Stein R; Goodman S; Benyunes MC; Ashby M; Jones DV; Fay J
Bone Marrow Transplant; 2001 Feb; 27(3):261-8. PubMed ID: 11277173
[TBL] [Abstract][Full Text] [Related]
29. Recombinant human thrombopoietin improves platelet counts and reduces platelet transfusion possibility among patients with severe sepsis and thrombocytopenia: a prospective study.
Wu Q; Ren J; Wu X; Wang G; Gu G; Liu S; Wu Y; Hu D; Zhao Y; Li J
J Crit Care; 2014 Jun; 29(3):362-6. PubMed ID: 24405656
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human thrombopoietin in critically ill patients with sepsis-associated thrombocytopenia: A clinical study.
Liu Y; Jin G; Sun J; Wang X; Guo L
Int J Infect Dis; 2020 Sep; 98():144-149. PubMed ID: 32561426
[TBL] [Abstract][Full Text] [Related]
31. [A prospective study of the efficacy and safety of maintenance therapy with recombinant human thrombopoietin in patients with primary immune thrombocytopenia: a multicenter study].
Cai HC; Wang SJ; Fu L; Wang XM; Hou M; Qin P; Chen FP; Zhang XH; Huang H; He JS; Wu RH; Ma JY; Yang RC; Liu XF; Tian Y; Liu AJ; Wu JS; Zhu WW; Zhou YH; Liu WB; Hu Y; He WJ; Li Y; Pan D; Zhao YQ
Zhonghua Xue Ye Xue Za Zhi; 2017 May; 38(5):379-383. PubMed ID: 28565735
[No Abstract] [Full Text] [Related]
32. [Clinical Analysis of Recombinant Human Thrombopoietin for Treatment of 46 Adult Patients with Newly Diagnosed Primary Immune Thrombocytopenia].
Wang M; Liu YF; Sun H; Xie XS; Ma J; Gan SL; Dong YJ; Ren HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):531-5. PubMed ID: 27151024
[TBL] [Abstract][Full Text] [Related]
33. [Therapeutic Effect of Combined Cytokines on Nonhuman Primate Model of Severe Haemopoietic Acute Radiation Sickness].
Ma YC; Li M; Xing S; Xiong GL; Shen X; Chen Q; Cong YW; Wang JX; Zhu NK; Yu ZY; Zhang XG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):573-9. PubMed ID: 27151032
[TBL] [Abstract][Full Text] [Related]
34. Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer.
Vadhan-Raj S; Verschraegen CF; Bueso-Ramos C; Broxmeyer HE; Kudelkà AP; Freedman RS; Edwards CL; Gershenson D; Jones D; Ashby M; Kavanagh JJ
Ann Intern Med; 2000 Mar; 132(5):364-8. PubMed ID: 10691586
[TBL] [Abstract][Full Text] [Related]
35. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
[TBL] [Abstract][Full Text] [Related]
36. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
Bai CM; Zou XY; Zhao YQ; Han SM; Shan YD;
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):397-400. PubMed ID: 15061993
[TBL] [Abstract][Full Text] [Related]
37. [The role of recombinant human thrombopoietin in critically ill patients with sepsis-associated thrombocytopenia: a clinical study].
Dong F; Ma N; Chang S; Yang H; Gao M; Liu Q; Sun X; Liang M; Sun R
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1445-1449. PubMed ID: 33541495
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness and economic evaluation of rhTPO and rhIL-11 in the treatment of cancer therapy induced thrombocytopenia based on real-world research.
Gong FM; Liu FY; Ma X; Ma ST; Xiao HT; Jiang G; Qi TT
Front Pharmacol; 2024; 15():1288964. PubMed ID: 38327986
[No Abstract] [Full Text] [Related]
39. [Efficacy and safety analysis of eltrombopag and recombinant human thrombopoietin combined with immunosuppressive therapy for severe aplastic anemia].
Yuan FF; Zhang QL; Zhang LN; Xiong YY; Li MJ; Zhou H; Wei XD; Liu XJ; Song YP
Zhonghua Xue Ye Xue Za Zhi; 2021 Dec; 42(12):1021-1024. PubMed ID: 35045674
[No Abstract] [Full Text] [Related]
40. Efficacy and safety of high dose recombinant human thrombopoietin in the treatment of immune thrombocytopenia.
Wang X; Bi H; Liu L; Liu Y; Yin L; Yao J; Yu J; Tao W; Wei Y; Li Y; Yin L; Mu H; Du Y; Zhou Z
Platelets; 2023 Dec; 34(1):2271568. PubMed ID: 37941414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
